» Articles » PMID: 24882415

Newly Synthesized 'hidabeni' Chalcone Derivatives Potently Suppress LPS-induced NO Production Via Inhibition of STAT1, but Not NF-κB, JNK, and P38, Pathways in Microglia

Overview
Journal Biol Pharm Bull
Specialty Biochemistry
Date 2014 Jun 3
PMID 24882415
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Chalcones are open-chain flavonoids that are biosynthesized in various plants. Some of them possess anti-inflammatory activity. We previously found that chalcone glycosides from Brassica rapa L. 'hidabeni' suppress lipopolysaccharide (LPS)-induced nitric oxide (NO) production in rat microglia highly aggressively proliferating immortalized (HAPI) cells. In this study, to explore chalcone derivatives with potent NO inhibitory activity, we synthesized ten compounds based on 'hidabeni' chalcone and examined their effects on LPS-triggered inducible NO synthase (iNOS) expression and NO production. Compounds C4 and C10 potently inhibited NO production (IC50: 4.19, 2.88 µM, respectively). C4 and C10 suppressed LPS-induced iNOS expression via the inhibition of the signal transduction and activator of transcription 1 (STAT1), but not nuclear factor-kappa B (NF-κB), c-Jun N terminal kinase (JNK), and p38, pathways. C10, but not C4, inhibited activation of the MEK/extracellular signal-regulated kinase (ERK) pathway. C4 and C10 also suppressed LPS-induced expression of interferon regulatory factor 1 (IRF-1), which is an important transcription factor involved in iNOS expression. Our findings indicate that these chalcone derivatives are candidate compounds for preventing microglia-mediated neuroinflammation.

Citing Articles

Multienzymatic biotransformation of flavokawain B by entomopathogenic filamentous fungi: structural modifications and pharmacological predictions.

Chlipala P, Tronina T, Dymarska M, Urbaniak M, Kozlowska E, Stepien L Microb Cell Fact. 2024; 23(1):65.

PMID: 38402203 PMC: 10893614. DOI: 10.1186/s12934-024-02338-9.


Immunomodulatory activity of polysaccharides from by activating Akt/NF-κB signaling.

Guo W, Zhang Q, Du Y, Guo J, Zhao T, Bai L Chin Herb Med. 2022; 14(1):90-96.

PMID: 36120126 PMC: 9476711. DOI: 10.1016/j.chmed.2021.10.003.


Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence.

Salehi B, Quispe C, Chamkhi I, El Omari N, Balahbib A, Sharifi-Rad J Front Pharmacol. 2021; 11:592654.

PMID: 33536909 PMC: 7849684. DOI: 10.3389/fphar.2020.592654.


Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors.

Yang S, Shergalis A, Lu D, Kyani A, Liu Z, Ljungman M J Med Chem. 2019; 62(7):3447-3474.

PMID: 30759340 PMC: 8276234. DOI: 10.1021/acs.jmedchem.8b01951.


Chalcone: A Privileged Structure in Medicinal Chemistry.

Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z Chem Rev. 2017; 117(12):7762-7810.

PMID: 28488435 PMC: 6131713. DOI: 10.1021/acs.chemrev.7b00020.